Bacterial oncogenesis in the colon

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin.61(2),69–90 (2011).
  MedlineGoogle Scholar
• 2  Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev.18(6),1688–1694 (2009).
  MedlineGoogle Scholar
• 3  Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J. Clin.59(6),366–378 (2009).
  MedlineGoogle Scholar
• 4  Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell61(5),759–767 (1990).
  Medline CASGoogle Scholar
• 5  Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet.9(4),138–141 (1993).
  Medline CASGoogle Scholar
• 6  Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science308(5728),1635–1638 (2005).▪ A 16S RNA analysis of mucosal-associated and fecal bacteria from three people over time that demonstrated significant variation between bacteria identified in stool versus mucosa within individuals, as well as in bacteria identified between individuals.
  MedlineGoogle Scholar
• 7  Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell122(1),107–118 (2005).
  Medline CASGoogle Scholar
• 8  Reikvam DH, Erofeev A, Sandvik A et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS ONE6(3),e17996 (2011).
  Medline CASGoogle Scholar
• 9  Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol.37(9),1034–1041 (2002).
  Medline CASGoogle Scholar
• 10  Rowland IR. The role of the gastrointestinal microbiota in colorectal cancer. Curr. Pharm. Des.15(13),1524–1527 (2009).
  Medline CASGoogle Scholar
• 11  Sheng YH, Hasnain SZ, Florin TH, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J. Gastroenterol. Hepatol.27(1),28–38 (2012).
  Medline CASGoogle Scholar
• 12  McGuckin MA, Linden SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol.9(4),265–278 (2011).
  Medline CASGoogle Scholar
• 13  Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions. Proc. Natl Acad. Sci. USA108(Suppl. 1),4659–4665 (2011).
  Medline CASGoogle Scholar
• 14  Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut40(6),782–789 (1997).
  Medline CASGoogle Scholar
• 15  Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature449(7164),804–810 (2007).
  Medline CASGoogle Scholar
• 16  Ahmed S, Macfarlane GT, Fite A, McBain AJ, Gilbert P, Macfarlane S. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl. Environ. Microbiol.73(22),7435–7442 (2007).
  Medline CASGoogle Scholar
• 17  Shen XJ, Rawls JF, Randall T et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes1(3),138–147 (2010).
  MedlineGoogle Scholar
• 18  Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular–phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA104(34),13780–13785 (2007).
  Medline CASGoogle Scholar
• 19  Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in Crohn’s disease and ulcerative colitis – an overview. J. Physiol. Pharmacol.60(Suppl. 6),61–71 (2009).
  MedlineGoogle Scholar
• 20  Tarmin L, Yin J, Harpaz N et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res.55(10),2035–2038 (1995).
  Medline CASGoogle Scholar
• 21  Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J. Gastroenterol.14(3),378–389 (2008).
  Medline CASGoogle Scholar
• 22  Marchesi JR, Dutilh BE, Hall N et al. Towards the human colorectal cancer microbiome. PLoS ONE6(5),e20447 (2011).
  Medline CASGoogle Scholar
• 23  Kostic AD, Gevers D, Pedamallu CS et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res.22(2),292–298 (2012).▪ This human colorectal cancer microbiome study utilized 454 sequencing, real-time PCR and FISH to identify an increased association between Fusobacterium and colon tumors when compared with flanking tissues (published in the same issue as [126]).
  Medline CASGoogle Scholar
• 24  Pitari GM, Zingman LV, Hodgson DM et al. Bacterial enterotoxins are associated with resistance to colon cancer. Proc. Natl Acad. Sci. USA100(5),2695–2699 (2003).
  Medline CASGoogle Scholar
• 25  Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet357(9255),539–545 (2001).
  Medline CASGoogle Scholar
• 26  Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell140(6),883–899 (2010).
  Medline CASGoogle Scholar
• 27  Coussens LM, Werb Z. Inflammation and cancer. Nature420(6917),860–867 (2002).
  Medline CASGoogle Scholar
• 28  Karin M, Greten FR. NFκB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol.5(10),749–759 (2005).
  Medline CASGoogle Scholar
• 29  Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J. Gastroenterol.16(43),5395–5404 (2010).
  MedlineGoogle Scholar
• 30  Goodwin AC, Destefano Shields CE, Wu S et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc. Natl Acad. Sci. USA108(37),15354–15359 (2011).
  Medline CASGoogle Scholar
• 31  Waris G, Ahsan H. Reactive oxygen species. role in the development of cancer and various chronic conditions. J. Carcinog.5,14 (2006).
  MedlineGoogle Scholar
• 32  Lax AJ. Opinion. Bacterial toxins and cancer – a case to answer? Nat. Rev. Microbiol.3(4),343–349 (2005).
  Medline CASGoogle Scholar
• 33  Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology125(6),1636–1644 (2003).
  MedlineGoogle Scholar
• 34  Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer2(1),28–37 (2002).
  Medline CASGoogle Scholar
• 35  Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci.96(12),835–843 (2005).
  Medline CASGoogle Scholar
• 36  Brandt S, Kwok T, Hartig R, Konig W, Backert S. NFκB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl Acad. Sci. USA102(26),9300–9305 (2005).
  Medline CASGoogle Scholar
• 37  Lamb A, Yang XD, Tsang YH et al.Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep.10(11),1242–1249 (2009).
  Medline CASGoogle Scholar
• 38  Franco AT, Israel DA, Washington MK et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad. Sci. USA102(30),10646–10651 (2005).
  Medline CASGoogle Scholar
• 39  Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl Acad. Sci. USA108(22),9238–9243 (2011).
  Medline CASGoogle Scholar
• 40  Miehlke S, Kirsch C, Agha-Amiri K et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer87(3),322–327 (2000).
  Medline CASGoogle Scholar
• 41  Strowski MZ, Cramer T, Schafer G et al.Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. FASEB J.18(1),218–220 (2004).
  Medline CASGoogle Scholar
• 42  Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science301(5636),1099–1102 (2003).
  Medline CASGoogle Scholar
• 43  Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res.63(5),951–957 (2003).
  Medline CASGoogle Scholar
• 44  Preuss I, Hildebrand D, Orth JH, Aktories K, Kubatzky KF. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways. Cell. Microbiol.12(8),1174–1185 (2010).
  Medline CASGoogle Scholar
• 45  Orth JH, Aktories K. Molecular biology of Pasteurella multocida toxin. Curr. Top. Microbiol. Immunol.361,73–92 (2012).
  Medline CASGoogle Scholar
• 46  Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K. Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc. Natl Acad. Sci. USA106(17),7179–7184 (2009).
  Medline CASGoogle Scholar
• 47  Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology157(Pt 7),1851–1875 (2011).
  Medline CASGoogle Scholar
• 48  Elwell C, Chao K, Patel K, Dreyfus L. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun.69(5),3418–3422 (2001).
  Medline CASGoogle Scholar
• 49  Nougayrede JP, Homburg S, Taieb F et al.Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science313(5788),848–851 (2006).
  Medline CASGoogle Scholar
• 50  Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA107(25),11537–11542 (2010).
  Medline CASGoogle Scholar
• 51  Arthur JC, Perez-Chanona E, Muhlbauer M et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science338(6103),120–123 (2012).▪ This murine study demonstrated that IL10-deficient mice colonized with Escherichia coli NC101 (pks+) develop invasive colon cancer independent of inflammation, and also provided evidence correlating this strain with colorectal cancer in humans.
  Medline CASGoogle Scholar
• 52  Miraglia AG, Travaglione S, Meschini S et al. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IκB kinase pathway. role of nuclear factor-kappaB and Bcl-2. Mol. Biol. Cell18(7),2735–2744 (2007).
  Medline CASGoogle Scholar
• 53  Samba-Louaka A, Nougayrede JP, Watrin C, Oswald E, Taieb F. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect. Immun.77(12),5471–5477 (2009).
  Medline CASGoogle Scholar
• 54  Wu S, Rhee KJ, Albesiano E et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med.15(9),1016–1022 (2009).▪ Identifies enterotoxigenic Bacteroides fragilis as being capable of inducing tumorigenesis in Apc+/- multiple intestinal neoplasia mice through a Th17-dependent mechanism.
  Medline CASGoogle Scholar
• 55  Toprak NU, Yagci A, Gulluoglu BM et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect.12(8),782–786 (2006).
  Medline CASGoogle Scholar
• 56  Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese–Hawaiians. Appl. Microbiol.27(5),961–979 (1974).
  Medline CASGoogle Scholar
• 57  Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann. Intern. Med.86(5),569–571 (1977).
  Medline CASGoogle Scholar
• 58  Rhee KJ, Wu S, Wu X et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect. Immun.77(4),1708–1718 (2009).
  Medline CASGoogle Scholar
• 59  Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci.49(9),1425–1432 (2004).
  MedlineGoogle Scholar
• 60  Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J Jr. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis.6(2),171–174 (2000).
  Medline CASGoogle Scholar
• 61  Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev.22(2),349–369 (2009).
  Medline CASGoogle Scholar
• 62  Zitomersky NL, Coyne MJ, Comstock LE. Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. Infect. Immun.79(5),2012–2020 (2011).
  Medline CASGoogle Scholar
• 63  Franco AA, Mundy LM, Trucksis M, Wu S, Kaper JB, Sears CL. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect. Immun.65(3),1007–1013 (1997).
  Medline CASGoogle Scholar
• 64  Franco AA. The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon. J. Bacteriol.186(18),6077–6092 (2004).
  Medline CASGoogle Scholar
• 65  Wu S, Lim KC, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl Acad. Sci. USA95(25),14979–14984 (1998).
  Medline CASGoogle Scholar
• 66  Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology124(2),392–400 (2003).
  Medline CASGoogle Scholar
• 67  Wu S, Powell J, Mathioudakis N, Kane S, Fernandez E, Sears CL. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway. Infect. Immun.72(10),5832–5839 (2004).
  Medline CASGoogle Scholar
• 68  Su LK, Kinzler KW, Vogelstein B et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science256(5057),668–670 (1992).
  Medline CASGoogle Scholar
• 69  Fodde R, Edelmann W, Yang K et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA91(19),8969–8973 (1994).
  Medline CASGoogle Scholar
• 70  Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature487(7407),330–337 (2012).▪ First report of the Cancer Genome Atlas project profiling genetic alterations in 276 colorectal carcinoma samples, demonstrating significant similarity in patterns of genetic alterations from patient to patient.
  Medline CASGoogle Scholar
• 71  Liu J, Duan Y, Cheng X et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem. Biophys. Res. Commun.407(2),348–354 (2011).
  Medline CASGoogle Scholar
• 72  Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc. Natl Acad. Sci. USA107(12),5540–5544 (2010).
  Medline CASGoogle Scholar
• 73  Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol.184(3),1630–1641 (2010).
  Medline CASGoogle Scholar
• 74  Sobhani I, Tap J, Roudot-Thoraval F et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE6(1),e16393 (2011).
  Medline CASGoogle Scholar
• 75  Morikawa T, Baba Y, Yamauchi M et al. STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers. Clin. Cancer Res.17(6),1452–1462 (2011).
  Medline CASGoogle Scholar
• 76  Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science247(4940),322–324 (1990).
  Medline CASGoogle Scholar
• 77  Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl Acad. Sci. USA92(10),4482–4486 (1995).
  Medline CASGoogle Scholar
• 78  Velcich A, Yang W, Heyer J et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science295(5560),1726–1729 (2002).
  Medline CASGoogle Scholar
• 79  Berg DJ, Davidson N, Kuhn R et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4⁺ Th1-like responses. J. Clin. Invest.98(4),1010–1020 (1996).
  Medline CASGoogle Scholar
• 80  Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell94(6),703–714 (1998).
  Medline CASGoogle Scholar
• 81  Rudolph U, Finegold MJ, Rich SS et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet.10(2),143–150 (1995).
  Medline CASGoogle Scholar
• 82  Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell92(5),645–656 (1998).
  Medline CASGoogle Scholar
• 83  Funabashi H, Uchida K, Kado S, Matsuoka Y, Ohwaki M. Establishment of a Tcrb and Trp53 genes deficient mouse strain as an animal model for spontaneous colorectal cancer. Exp. Anim.50(1),41–47 (2001).
  Medline CASGoogle Scholar
• 84  Chu FF, Esworthy RS, Chu PG et al. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res.64(3),962–968 (2004).
  Medline CASGoogle Scholar
• 85  Engle SJ, Ormsby I, Pawlowski S et al. Elimination of colon cancer in germ-free transforming growth factor β 1-deficient mice. Cancer Res.62(22),6362–6366 (2002).
  Medline CASGoogle Scholar
• 86  Taketo MM, Edelmann W. Mouse models of colon cancer. Gastroenterology136(3),780–798 (2009).
  Medline CASGoogle Scholar
• 87  Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in IL-10 knockout mice. Am. J. Pathol.160(6),2253–2257 (2002).
  Medline CASGoogle Scholar
• 88  Dove WF, Clipson L, Gould KA et al. Intestinal neoplasia in the Apc^Min mouse. independence from the microbial and natural killer (beige locus) status. Cancer Res.57(5),812–814 (1997).
  Medline CASGoogle Scholar
• 89  Li Y, Kundu P, Seow SW et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC^Min/+ mice. Carcinogenesis33(6),1231–1238 (2012).
  Medline CASGoogle Scholar
• 90  Kado S, Uchida K, Funabashi H et al. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res.61(6),2395–2398 (2001).
  Medline CASGoogle Scholar
• 91  Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE4(6),e6026 (2009).
  MedlineGoogle Scholar
• 92  Johansson ME, Gustafsson JK, Sjoberg KE et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS ONE5(8),e12238 (2010).
  MedlineGoogle Scholar
• 93  Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol.2012,718617 (2012).
  MedlineGoogle Scholar
• 94  Elinav E, Strowig T, Kau AL et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell145(5),745–757 (2011).
  Medline CASGoogle Scholar
• 95  Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science334(6052),105–108 (2011).
  Medline CASGoogle Scholar
• 96  Garrett WS, Lord GM, Punit S et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell131(1),33–45 (2007).
  Medline CASGoogle Scholar
• 97  Vijay-Kumar M, Aitken JD, Carvalho FA et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science328(5975),228–231 (2010).
  Medline CASGoogle Scholar
• 98  Hans W, Scholmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur. J. Gastroenterol. Hepatol.12(3),267–273 (2000).
  Medline CASGoogle Scholar
• 99  Rath HC, Schultz M, Freitag R et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun.69(4),2277–2285 (2001).
  Medline CASGoogle Scholar
• 100  Fukuda M, Kanauchi O, Araki Y et al. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int. J. Mol. Med.9(1),65–70 (2002).
  Medline CASGoogle Scholar
• 101  Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp. Anim.50(5),387–395 (2001).
  Medline CASGoogle Scholar
• 102  Ellmerich S, Scholler M, Duranton B et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis21(4),753–756 (2000).
  Medline CASGoogle Scholar
• 103  Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. Camb. Philos. Soc.87(3),701–730 (2012).
  MedlineGoogle Scholar
• 104  Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol.4(1),22–30 (2011).
  Medline CASGoogle Scholar
• 105  Erdman SE, Rao VP, Poutahidis T et al. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc. Natl Acad. Sci. USA106(4),1027–1032 (2009).
  Medline CASGoogle Scholar
• 106  Mangerich A, Knutson CG, Parry NM et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc. Natl Acad. Sci. USA109(27),E1820–E1829 (2012).
  MedlineGoogle Scholar
• 107  Balagopal A, Philp FH, Astemborski J et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology135(1),226–233 (2008).
  Medline CASGoogle Scholar
• 108  Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol.21(1),6–13 (2013).
  Medline CASGoogle Scholar
• 109  Huycke MM, Moore D, Joyce W et al. Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol. Microbiol.42(3),729–740 (2001).
  Medline CASGoogle Scholar
• 110  Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res.68(23),9909–9917 (2008).
  Medline CASGoogle Scholar
• 111  Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol.174(5),2990–2999 (2005).
  Medline CASGoogle Scholar
• 112  Winters MD, Schlinke TL, Joyce WA, Glore SR, Huycke MM. Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancer. Am. J. Gastroenterol.93(12),2491–2500 (1998).
  Medline CASGoogle Scholar
• 113  Barthold SW, Osbaldiston GW, Jonas AM. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab. Anim. Sci.27(6),938–945 (1977).
  Medline CASGoogle Scholar
• 114  Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB. Bacterial infection promotes colon tumorigenesis in Apc^Min/+ mice. J. Infect. Dis.184(2),227–230 (2001).
  Medline CASGoogle Scholar
• 115  Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS ONE4(5),e5517 (2009).
  MedlineGoogle Scholar
• 116  Keusch GT. Opportunistic infections in colon carcinoma. Am. J. Clin. Nutr.27(12),1481–1485 (1974).
  Medline CASGoogle Scholar
• 117  Kok H, Jureen R, Soon CY, Tey BH. Colon cancer presenting as Streptococcus gallolyticus infective endocarditis. Singapore Med. J.48(2),e43–e45 (2007).
  Medline CASGoogle Scholar
• 118  Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med.297(15),800–802 (1977).
  Medline CASGoogle Scholar
• 119  Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis.53(9),870–878 (2011).
  Medline CASGoogle Scholar
• 120  Boleij A, Muytjens CM, Bukhari SI et al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J. Infect. Dis.203(8),1101–1109 (2011).
  Medline CASGoogle Scholar
• 121  Corredoira-Sanchez J, Garcia-Garrote F, Rabunal R et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case–control study. Clin. Infect. Dis.55(4),491–496 (2012).
  MedlineGoogle Scholar
• 122  Schlegel L, Grimont F, Ageron E, Grimont PA, Bouvet A. Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int. J. Syst. Evol. Microbiol.53(Pt 3),631–645 (2003).
  Medline CASGoogle Scholar
• 123  Seder CW, Kramer M, Long G, Uzieblo MR, Shanley CJ, Bove P. Clostridium septicum aortitis: report of two cases and review of the literature. J. Vasc. Surg.49(5),1304–1309 (2009).
  MedlineGoogle Scholar
• 124  Wang T, Cai G, Qiu Y et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J.6(2),320–329 (2012).
  Medline CASGoogle Scholar
• 125  Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE7(6),e39743 (2012).
  Medline CASGoogle Scholar
• 126  Castellarin M, Warren RL, Freeman JD et al.Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res.22(2),299–306 (2012).▪ This human colorectal cancer microbiome study utilized 454 sequencing, real-time PCR and FISH to identify an increased association between Fusobacterium and colon tumors when compared with flanking tissues (published in the same issue as [23]).
  Medline CASGoogle Scholar
• 127  Swidsinski A, Khilkin M, Kerjaschki D et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology115(2),281–286 (1998).
  Medline CASGoogle Scholar
• 128  Uemura N, Okamoto S, Yamamoto S et al.Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med.345(11),784–789 (2001).
  Medline CASGoogle Scholar
• 129  Sears CL, Pardoll DM. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis.203(3),306–311 (2011).
  MedlineGoogle Scholar
• 130  Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol.10(8),575–582 (2012).
  Medline CASGoogle Scholar
• 131  Hand TW, Dos Santos LM, Bouladoux N et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science337(6101),1553–1556 (2012).
  Medline CASGoogle Scholar
• 132  Evans AS. Causation and disease: the Henle–Koch postulates revisited. Yale J. Biol. Med.49(2),175–195 (1976).
  Medline CASGoogle Scholar